Fig. 3From: Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancerReceiver operator characteristic curves presenting sarcopenia and low skeletal muscle mass according to serum creatinine (Cr)/cystatin C (CysC) ratio, serum CysC and serum Cr levelsBack to article page